Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.

Bleesing J, Prada A, Siegel DM, Villanueva J, Olson J, Ilowite NT, Brunner HI, Griffin T, Graham TB, Sherry DD, Passo MH, Ramanan AV, Filipovich A, Grom AA.

Arthritis Rheum. 2007 Mar;56(3):965-71.

2.

Soluble CD163.

Møller HJ.

Scand J Clin Lab Invest. 2012 Feb;72(1):1-13. doi: 10.3109/00365513.2011.626868. Epub 2011 Nov 7. Review.

PMID:
22060747
3.

Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

Ravelli A, Magni-Manzoni S, Pistorio A, Besana C, Foti T, Ruperto N, Viola S, Martini A.

J Pediatr. 2005 May;146(5):598-604. Review.

PMID:
15870661
4.

Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review.

Bien E, Balcerska A.

Biomarkers. 2008 Feb;13(1):1-26. Review.

PMID:
17906988
5.

Recognition and management of macrophage activation syndrome in juvenile arthritis.

Kelly A, Ramanan AV.

Curr Opin Rheumatol. 2007 Sep;19(5):477-81. Review.

PMID:
17762614
6.

Macrophage activation syndrome: serological markers and treatment with anti-thymocyte globulin.

Coca A, Bundy KW, Marston B, Huggins J, Looney RJ.

Clin Immunol. 2009 Jul;132(1):10-8. doi: 10.1016/j.clim.2009.02.005. Epub 2009 Mar 17. Review.

PMID:
19297252
7.

Macrophage activation syndrome.

Ravelli A.

Curr Opin Rheumatol. 2002 Sep;14(5):548-52. Review.

PMID:
12192253
8.

CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response.

Moestrup SK, Møller HJ.

Ann Med. 2004;36(5):347-54. Review.

PMID:
15478309
9.

Macrophage activation syndrome and other systemic inflammatory conditions after BMT.

Sreedharan A, Bowyer S, Wallace CA, Robertson MJ, Schmidt K, Woolfrey AE, Nelson RP Jr.

Bone Marrow Transplant. 2006 Apr;37(7):629-34. Review.

PMID:
16501594
10.

Interleukin 6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis.

Yokota S.

Curr Opin Rheumatol. 2003 Sep;15(5):581-6. Review.

PMID:
12960484
11.

Macrophage activation syndrome in juvenile idiopathic arthritis.

Cortis E, Insalaco A.

Acta Paediatr Suppl. 2006 Jul;95(452):38-41. Review.

PMID:
16801165
12.

Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients.

Parodi A, Davì S, Pringe AB, Pistorio A, Ruperto N, Magni-Manzoni S, Miettunen P, Bader-Meunier B, Espada G, Sterba G, Ozen S, Wright D, Magalhães CS, Khubchandani R, Michels H, Woo P, Iglesias A, Guseinova D, Bracaglia C, Hayward K, Wouters C, Grom A, Vivarelli M, Fischer A, Breda L, Martini A, Ravelli A; Lupus Working Group of the Paediatric Rheumatology European Society.

Arthritis Rheum. 2009 Nov;60(11):3388-99. doi: 10.1002/art.24883. Review.

13.

The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age.

Stabile A, Bertoni B, Ansuini V, La Torraca I, Sallì A, Rigante D.

Eur Rev Med Pharmacol Sci. 2006 Mar-Apr;10(2):53-9. Review.

PMID:
16705949
14.

Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis.

Yokota S, Miyamae T, Imagawa T, Katakura S, Kurosawa R, Mori M.

Clin Rev Allergy Immunol. 2005 Jun;28(3):231-8. Review.

PMID:
16129907
15.

Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication?

Pringe A, Trail L, Ruperto N, Buoncompagni A, Loy A, Breda L, Martini A, Ravelli A.

Lupus. 2007;16(8):587-92. Review.

PMID:
17711893
16.

Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis?

Ramanan AV, Grom AA.

Rheumatology (Oxford). 2005 Nov;44(11):1350-3. Epub 2005 Jun 14. Review.

17.
18.

Diagnostic and prognostic potential of the macrophage specific receptor CD163 in inflammatory diseases.

Buechler C, Eisinger K, Krautbauer S.

Inflamm Allergy Drug Targets. 2013 Dec;12(6):391-402. Review.

PMID:
24090317
19.

Targeting the interleukin-6 receptor: a new treatment for systemic juvenile idiopathic arthritis?

de Benedetti F, Martini A.

Arthritis Rheum. 2005 Mar;52(3):687-93. Review. No abstract available.

20.

Systemic onset juvenile rheumatoid arthritis.

Schneider R, Laxer RM.

Baillieres Clin Rheumatol. 1998 May;12(2):245-71. Review.

PMID:
9890097
Items per page

Supplemental Content

Write to the Help Desk